Back to Results
First PageMeta Content
Kidney cancer / Organofluorides / Pyridines / Indoles / Pyrroles / Sunitinib / Sorafenib / Temsirolimus / Axitinib / Chemistry / Organic chemistry / Medicine


Negative Trials in RCC: Where Did We Go Wrong? Can We Do Better? 9th European Kidney Cancer Symposium, Dublin, April 2014 Tim Eisen
Add to Reading List

Document Date: 2014-05-13 15:16:02

Open Document

File Size: 1,91 MB

Share Result on Facebook

City

Dublin / /

Company

Astra / Bayer / Glaxosmithkline plc / /

Event

FDA Phase / /

MedicalCondition

very-high-risk disease / Cancer / tumour / high-risk disease / /

NaturalFeature

EVEREST / /

Organization

FDA / /

Person

Tim Eisen Tim Eisen / /

Position

Governor / /

Product

IL-2 / SORCE1 / /

URL

www.clinicaltrials.gov / /

SocialTag